Patent Application
20190298506
Not Applicable
Not Applicable
Not Applicable
Not Applicable
Not Applicable
The disclosure and prior art relates to shielding devices and more particularly pertains to a new shielding device for preventing urinary tract infections.
An embodiment of the disclosure meets the needs presented above by generally comprising a panel that is finely meshed so that the panel is configured to prevent passage of a microorganism through the panel. A first coupler is coupled to a first side of the panel so that the panel is configured to couple to a pelvic region of a female user. The panel is positioned over an external urethral orifice of the user to prevent the microorganism from entering a urethra of the user.
There has thus been outlined, rather broadly, the more important features of the disclosure in order that the detailed description thereof that follows may be better understood, and in order that the present contribution to the art may be better appreciated.
There are additional features of the disclosure that will be described hereinafter and which will form the subject matter of the claims appended hereto.
The objects of the disclosure, along with the various features of novelty which characterize the disclosure, are pointed out with particularity in the claims annexed to and forming a part of this disclosure.
The disclosure will be better understood and objects other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such description makes reference to the annexed drawings wherein:
With reference now to the drawings, and in particular to
As best illustrated in
A first coupler 24 is coupled to a first side 26 of the panel 12 so that the panel 12 is configured to couple to a pelvic region of a female user. The panel 12 is positioned over an external urethral orifice of the user, as shown in
The first coupler 24 comprises a first strip 28 that is coupled to the panel 12. The first strip 28 extends along the opposing sides 16 and the top 18 of the panel 12, as shown in
A second strip 30 is reversibly coupled to the first strip 28, as shown in
The second strip 30 is positioned to be selectively removed to position the first strip 28 to couple to the pelvic region of the user.
A second coupler 32 is coupled to a second side 34 of the panel 12, as shown in
The second coupler 32 comprises a pair of third strips 36 that are coupled to the panel 12. The third strips 36 comprise adhesive. Each third strip 36 extends perpendicularly from proximate to the bottom 20 toward the top 18 of the panel 12. The third strips 36 are positioned to bracket the external urethral orifice when the user is wearing the undergarment.
Each of a pair of fourth strips 38 is reversibly coupled to a respective third strip 36. Each fourth strip 38 is positioned to be selectively removed to position the respective third strip 36 to couple to the undergarment.
In use, the first strip 28 is configured to adhesively couple the panel 12 to the pelvic region of the user. The bottom 20 of the panel 12 is positioned between the external urethral orifice and the vaginal opening of the user. The panel 12 is positioned over the external urethral orifice to prevent the microorganism from entering the urethra, thus preventing the urinary tract infection.
With respect to the above description then, it is to be realized that the optimum dimensional relationships for the parts of an embodiment enabled by the disclosure, to include variations in size, materials, shape, form, function and manner of operation, assembly and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by an embodiment of the disclosure.
Therefore, the foregoing is considered as illustrative only of the principles of the disclosure. Further, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the disclosure to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the disclosure. In this patent document, the word “comprising” is used in its non-limiting sense to mean that items following the word are included, but items not specifically mentioned are not excluded. A reference to an element by the indefinite article “a” does not exclude the possibility that more than one of the element is present, unless the context clearly requires that there be only one of the elements.
